Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study - PubMed (original) (raw)
Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study
C D Sjöström et al. Obes Res. 1999 Sep.
Free article
Abstract
Objective: To examine the effect of a large, long standing and intentional weight reduction on the incidence of diabetes, hypertension and lipid disturbances in severely obese individuals as compared to weight-stable obese controls.
Research methods and procedures: The ongoing prospective SOS (Swedish Obese Subjects) intervention consists of a surgically treated group and a matched control group obtaining conventional obesity treatment. This report is based on 845 surgically treated patients and 845 controls (BMI 41.0+/-4.6 kg/m2 (mean+/-standard deviation [S])) followed for 2 years.
Results: Surgically treated patients lost 28+/-15 kg and controls 0.5+/-8.9 kg (p<0.0001). Two-year incidence of hypertension, diabetes, hyperinsulinemia, and lipid disturbances was compared in the two treatment groups. Adjusted odds ratios (95% CI) for the surgically treated group versus controls were 0.38 (0.22, 0.65) for hypertension, 0.02 (0.00, 0.16) for diabetes, 0.10 (0.03, 0.28) for hyperinsulinemia, 0. 10 (0.04, 0.25) for hypertriglyceridemia, 0.28 (0.16, 0.49) for low HDL-cholesterol and 1.24 (0.84, 1.8) for hypercholesterolemia. Compared to controls, the 2-year recovery rates from hypertension, diabetes, hypo-HDL, and hypertriglyceridemia were significantly higher in the surgically treated group.
Discussion: Intentional weight loss in the obese causes a marked reduction in the 2-year incidence of hypertension, diabetes and some lipid disturbances. The results suggest that severe obesity can and should be treated.
Similar articles
- Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.
Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H; Swedish Obese Subjects Study Scientific Group. Sjöström L, et al. N Engl J Med. 2004 Dec 23;351(26):2683-93. doi: 10.1056/NEJMoa035622. N Engl J Med. 2004. PMID: 15616203 Clinical Trial. - [Bariatric surgery: 10-year results of the Swedish Obese Subjects Study].
Scheen AJ, Letiexhe M, Rorive M, De Flines J, Luyckx FH, Desaive C. Scheen AJ, et al. Rev Med Liege. 2005 Feb;60(2):121-5. Rev Med Liege. 2005. PMID: 15819376 Clinical Trial. French. - Differentiated long-term effects of intentional weight loss on diabetes and hypertension.
Sjöström CD, Peltonen M, Wedel H, Sjöström L. Sjöström CD, et al. Hypertension. 2000 Jul;36(1):20-5. doi: 10.1161/01.hyp.36.1.20. Hypertension. 2000. PMID: 10904007 - Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery.
Sjöström L. Sjöström L. J Intern Med. 2013 Mar;273(3):219-34. doi: 10.1111/joim.12012. Epub 2013 Feb 8. J Intern Med. 2013. PMID: 23163728 Review. - The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ. Picot J, et al. Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410. Health Technol Assess. 2009. PMID: 19726018 Review.
Cited by
- Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape-focus on hypertriglyceridaemia.
Bashir B, Schofield J, Downie P, France M, Ashcroft DM, Wright AK, Romeo S, Gouni-Berthold I, Maan A, Durrington PN, Soran H. Bashir B, et al. Front Cardiovasc Med. 2024 Aug 7;11:1389106. doi: 10.3389/fcvm.2024.1389106. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39171323 Free PMC article. Review. - The impact of bariatric surgery on pregnancy complication rates.
Empey R, Alexander A, Horns JJ, Das R, Ibele A. Empey R, et al. Surg Endosc. 2024 Oct;38(10):5929-5934. doi: 10.1007/s00464-024-11050-z. Epub 2024 Jul 24. Surg Endosc. 2024. PMID: 39048739 - The relation between excess adiposity and breast cancer in women: Clinical implications and management.
Hurtado MD, Tama E, D'Andre S, Shufelt CL. Hurtado MD, et al. Crit Rev Oncol Hematol. 2024 Jan;193:104213. doi: 10.1016/j.critrevonc.2023.104213. Epub 2023 Nov 24. Crit Rev Oncol Hematol. 2024. PMID: 38008197 Review. - Down-staging of obesity one year after bariatric surgery: a new proposal of Edmonton obesity staging system.
Quinto G, Bettini S, Neunhaeuserer D, Battista F, Milan G, Gasperetti A, Vecchiato M, Vettor R, Ermolao A, Busetto L. Quinto G, et al. Front Endocrinol (Lausanne). 2023 Jul 21;14:1147171. doi: 10.3389/fendo.2023.1147171. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37547310 Free PMC article. - Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials.
Popoviciu MS, Păduraru L, Yahya G, Metwally K, Cavalu S. Popoviciu MS, et al. Int J Mol Sci. 2023 Jun 21;24(13):10449. doi: 10.3390/ijms241310449. Int J Mol Sci. 2023. PMID: 37445623 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical